BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 21129786)

  • 1. A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.
    Ben-David H; Sharabi A; Parameswaran R; Zinger H; Mozes E
    Immunology; 2009 Oct; 128(2):245-52. PubMed ID: 19740381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photobiomodulation for Neurodegenerative Diseases: A Scoping Review.
    Shen Q; Guo H; Yan Y
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends.
    Lin H; Li D; Zhu J; Liu S; Li J; Yu T; Tuchin VV; Semyachkina-Glushkovskaya O; Zhu D
    Neurophotonics; 2024 Jan; 11(1):010601. PubMed ID: 38317779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease.
    Su M; Nizamutdinov D; Liu H; Huang JH
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus.
    Han X; Xu T; Ding C; Wang D; Yao G; Chen H; Fang Q; Hu G; Sun L
    Signal Transduct Target Ther; 2022 Feb; 7(1):50. PubMed ID: 35177587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches.
    Zarfeshani A; Carroll KR; Volpe BT; Diamond B
    Curr Rheumatol Rep; 2021 Mar; 23(4):25. PubMed ID: 33782842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus.
    Bendorius M; Po C; Muller S; Jeltsch-David H
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Photobiomodulation Therapy: a Narrative Review.
    Salehpour F; Mahmoudi J; Kamari F; Sadigh-Eteghad S; Rasta SH; Hamblin MR
    Mol Neurobiol; 2018 Aug; 55(8):6601-6636. PubMed ID: 29327206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis.
    Hsiao YH; Hung HC; Chen SH; Gean PW
    J Neurosci; 2014 Dec; 34(49):16207-19. PubMed ID: 25471562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient domoic acid excitotoxicity increases BDNF expression and activates both MEK- and PKA-dependent neurogenesis in organotypic hippocampal slices.
    Pérez-Gómez A; Tasker RA
    BMC Neurosci; 2013 Jul; 14():72. PubMed ID: 23865384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
    Parameswaran R; Ben David H; Sharabi A; Zinger H; Mozes E
    Clin Immunol; 2009 May; 131(2):223-32. PubMed ID: 19188092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosus.
    Mozes E; Sharabi A
    Autoimmun Rev; 2010 Nov; 10(1):22-6. PubMed ID: 20659591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric SLE: from animal model to human.
    Pikman R; Kivity S; Levy Y; Arango MT; Chapman J; Yonath H; Shoenfeld Y; Gofrit SG
    Lupus; 2017 Apr; 26(5):470-477. PubMed ID: 28394237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations.
    Telerman A; Lapter S; Sharabi A; Zinger H; Mozes E
    J Neuroimmunol; 2011 Mar; 232(1-2):151-7. PubMed ID: 21129786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide.
    Lapter S; Marom A; Meshorer A; Elmann A; Sharabi A; Vadai E; Neufeld A; Sztainberg Y; Gil S; Getselter D; Chen A; Mozes E
    Arthritis Rheum; 2009 Dec; 60(12):3744-54. PubMed ID: 19950283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gene expression in mice with lupus treated with edratide, a peptide that ameliorates the disease manifestations.
    Elmann A; Sharabi A; Dayan M; Zinger H; Ophir R; Mozes E
    Arthritis Rheum; 2007 Jul; 56(7):2371-81. PubMed ID: 17599765
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.